Neutrophil-to-lymphocyte Ratio and 5-year All-cause Mortality in Patients with Heart Failure

doi:10.12114/j.issn.1007-9572.2019.00.632

Abstract

Abstract: Background　The mortality rate of heart failure（HF） remains high.And there are limited clinical studies on the relationship between neutrophil-to-lymphocyte ratio（NLR） and 5-year all-cause mortality in such patients.Objective　To investigate the correlation between NLR and 5-year all-cause mortality in patients with HF.Methods　This study was a single-center retrospective study.418 adult patients with symptomatic HF（NYHA class Ⅲ-Ⅳ） hospitalized in the First Affiliated Hospital of Guangxi Medical University from August，2012 to July，2013 were enrolled.Clinical data and telephone-based follow-up results were collected to understand the 5-year all-cause mortality.The relationship between NLR and 5-year all-cause mortality was analyzed across quartile subgroups stratified by NLR value.Results　The 5-year all-cause mortality in the participants was 55.3%（231/418）．Univariate analysis showed that urea，creatinine，cystatin C，creatine kinase isozyme，plasma N-terminal B-type natriuretic peptide precursor，higher NYHA classes，and elevated NLR increased the risk of 5-year all-cause mortality in HF patients（P<0.05），whereas high weight and triglyceride，the use of β receptor blockers，and women decreased the risk（P<0.05）．After adjusting for other covariates，NLR remained an independent predictor of 5-year all-cause mortality（P<0.05）．Conclusion　NLR is an independent predictor of 5-year all-cause mortality in HF patients.The higher the ratio，the higher the risk.

Key words: Heart failure, Neutrophil, Lymphocyte, Mortality, Neutrophil-to-lymphocyte ratio

摘要：

背景　目前心力衰竭患者的死亡率仍然很高，且国内外关于中性粒细胞与淋巴细胞比值与心力衰竭患者5年全因死亡的相关性临床研究较为缺乏。目的　分析心力衰竭患者中性粒细胞与淋巴细胞比值与5年全因死亡的关系。方法　本研究为单中心回顾性研究，选取2012年8月—2013年7月于广西医科大学第一附属医院住院的成年症状性心力衰竭〔纽约心脏病协会（NYHA）心功能分级Ⅲ~Ⅳ级〕患者418例为研究对象，收集患者的临床资料并电话随访了解心力衰竭患者的5年全因死亡情况。根据患者中性粒细胞与淋巴细胞比值等分为4组，分析中性粒细胞与淋巴细胞比值与心力衰竭患者5年全因死亡率的关系。结果　本研究心力衰竭患者全因死亡率为55.3%（231/418）。单因素分析结果显示，尿素、肌酐、胱抑素C、肌酸激酶同工酶、N末端B型利钠肽前体、心功能分级、中性粒细胞与淋巴细胞比值高是心力衰竭患者5年全因死亡的危险因素（P<0.05），而体质量高、三酰甘油水平高、使用β-受体阻滞剂是心力衰竭患者5年全因死亡的保护因素（P<0.05），女性心力衰竭患者5年全因死亡发生风险低于男性（P<0.05）。在校正了多种混杂因素后，中性粒细胞与淋巴细胞比值仍然是心力衰竭患者5年全因死亡的独立预测因素（P<0.05）。结论　中性粒细胞与淋巴细胞比值是心力衰竭患者5年全因死亡的独立预测因素，比值越高，风险越大。

关键词: 心力衰竭, 中性粒细胞, 淋巴细胞, 死亡率, 中性粒细胞与淋巴细胞比值

LUO Faxin,YE Ziliang,ZHU Jijin. Neutrophil-to-lymphocyte Ratio and 5-year All-cause Mortality in Patients with Heart Failure　[J]. Chinese General Practice, 2019, 22(34): 4213-4219. DOI: 10.12114/j.issn.1007-9572.2019.00.632.
罗发新,叶自亮,朱继金. 心力衰竭患者中性粒细胞与淋巴细胞比值与5年全因死亡的关系研究[J]. 中国全科医学, 2019, 22(34): 4213-4219. DOI: 10.12114/j.issn.1007-9572.2019.00.632.

References

［1］PONIKOWSKI P，VOORS A A，ANKER S D，et al．2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure：the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology（ESC）developed with the special contribution of the Heart Failure Association（HFA）of the ESC［J］．Eur J Heart Fail，2016，18（8）：891-975．DOI：10.1002/ejhf.592.
［2］黄尧，操基玉，程自平．合肥某三甲医院2012—2014年心血管病住院患者流行病学分析［J］．安徽医学，2017，38（2）：144-146．DOI：10.3969/j.issn.1000-0399.2017.02.005.
HUANG Y，CAO J Y，CHENG Z P．Epidemiology analysis of inpatients with cardiovascular diseases in a certain hospital of Hefei in 2012—2014［J］．Anhui Medical Journal，2017，38（5）：144-146．DOI：10.3969/j.issn.1000-0399.2017.02.005.
［3］中华医学会心血管病学分会.中国心力衰竭诊断和治疗指南2014［J］．中华心血管病杂志，2014，42（2）：3-10.https：//wenku.baidu.com/view/3308024b6c85ec3a87c2c585.html.
［4］HE J Y，LI J，WANG Y F，et al．Neutrophil-to-lymphocyte ratio（NLR）predicts mortality and adverse-outcomes after ST-segment elevation myocardial infarction in Chinese people［J］．Int J Clin Exp Pathol，2014，7（7）：4045-4056.
［5］SAWANT A C，ADHIKARI P，NARRA S R，et al．Neutrophil to lymphocyte ratio predicts short- and long-term mortality following revascularization therapy for ST elevation myocardial infarction［J］．Cardiol J，2014，21（5）：500-508．DOI：10.5603/CJ.a2013.0148.
［6］WANG X D，ZHANG G Y，JIANG X J，et al．Neutrophil to lymphocyte ratio in relation to risk of all-cause mortality and cardiovascular events among patients undergoing angiography or cardiac revascularization：a meta-analysis of observational studies［J］．Atherosclerosis，2014，234（1）：206-213．DOI：10.1016/j.atherosclerosis.2014.03.003.
［7］MCMURRAY J J，ADAMOPOULOS S，ANKER S D，et al．ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012：the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology developed in collaboration with the Heart Failure Association（HFA）of the ESC［J］．Eur J Heart Fail，2012，14（8）：803-869．DOI：10.1093/eurjhf/hfs105.
［8］周京敏，崔晓通，葛均波.中国心力衰竭的流行病学概况［J］．中华心血管病杂志，2015，43（12）：1018-1021.http：//www.360doc.com/content/16/0928/18/17155989_594445555.shtml.
［9］ENGSTRO M G，MELANDER O，HEDBLAD B.Leukocyte count and incidence of hospitalizations due to heart failure［J］．Circ Heart Fail，2009，2（3）：217-222．DOI：10.1161/circheartfailure.108.827071.
［10］ARRUDA-OLSON A M，REEDER G S，BELL M R，et al．Neutrophilia predicts death and heart failure after myocardial infarction：a community-based study［J］．Circ Cardiovasc Qual Outcomes，2009，2（6）：656-662．DOI：10.1161/CIRCOUTCOMES.108.831024.
［11］RUDIGER A，BURCKHARDT O A，HARPES P，et al．The relative lymphocyte count on hospital admission is a risk factor for long-term mortality in patients with acute heart failure［J］．Am J Emerg Med，2006，24（4）：451-454．DOI：10.1016/j.ajem.2005.10.010.
［12］YAN W，LIU C L，LI R J，et al．Usefulness of the neutrophil-to-lymphocyte ratio in predicting adverse events in elderly patients with chronic heart failure［J］．Int Heart J，2016，57（5）：615-621．DOI：10.1536/ihj.16-049.
［13］WASILEWSKI J，PYKA L，HAWRANEK M，et al．Prognostic value of neutrophil?to?lymphocyte ratio in predicting long-term mortality in patients with ischemic and nonischemic heart failure［J］．Pol Arch Med Wewn，2016，126（3）：166-173．DOI：10.20452/pamw.3316.
［14］DURMUS E，KIVRAK T，GERIN F，et al．Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio are predictors of heart failure［J］．Arq Bras Cardiol，2015，105（6）：606-613．DOI：10.5935/abc.20150126.
［15］BENITES-ZAPATA V A，HERNANDEZ A V，NAGARAJAN V，et al．Usefulness of neutrophil-to-lymphocyte ratio in risk stratification of patients with advanced heart failure［J］．Am J Cardiol，2015，115（1）：57-61．DOI：10.1016/j.amjcard.2014.10.008.
［16］TASAL A，ERTURK M，UYAREL H，et al．Utility of the neutrophil to lymphocyte ratio for predicting in-hospital mortality after levosimendan infusion in patients with acute decompensated heart failure［J］．J Cardiol，2014，63（6）：418-423．DOI：10.1016/j.jjcc.2013.10.009.
［17］ROSS R.Atherosclerosis：an inflammatory disease［J］．N Engl J Med，1999，340（2）：115-126．DOI：10.1056/nejm199901143400207.
［18］TOUSOULIS D，ANTONIADES C，KOUMALLOS N，et al．Pro-inflammatory cytokines in acute coronary syndromes：from bench to bedside［J］．Cytokine Growth Factor Rev，2006，17（4）：225-233．DOI：10.1016/j.cytogfr.2006.04.003.
［19］TANG W H，TONG W，TROUGHTON R W，et al．Prognostic value and echocardiographic determinants of plasma myeloperoxidase levels in chronic heart failure［J］．J Am Coll Cardiol，2007，49（24）：2364-2370．DOI：10.1016/j.jacc.2007.02.053.
［20］CHEN W，FRANGOGIANNIS N G.The role of inflammatory and fibrogenic pathways in heart failure associated with aging［J］．Heart Fail Rev，2010，15（5）：415-422．DOI：10.1007/s10741-010-9161-y.
［21］CAK C M，CETIN M，DOGAN A，et al．Neutrophil to lymphocyte ratio predicts poor functional capacity in patients with heart failure［J］．Turk Kardiyol Dern Ars，2014，42（7）：612-620．DOI：10.5543/tkda.2014.16363.
［22］AZAB B，ZAHER M，WEISERBS K F，et al．Usefulness of neutrophil to lymphocyte ratio in predicting short- and long-term mortality after non-ST-elevation myocardial infarction［J］．Am J Cardiol，2010，106（4）：470-476．DOI：10.1016/j.amjcard.2010.03.062.
［23］HOTCHKISS R S，KARL I E．The pathophysiology and treatment of Sepsis［J］．N Engl J Med，2003，348（2）：138-150．DOI：10.1056/NEJMra021333.
［24］YüCEL H，REFIKEROEGE M，ZORLU A，et al．Lymphocytopenia is associated with poor NYHA functional class in chronic heart failure patients with reduced ejection fraction［J］．Turk Kardiyol Dern Ars，2015，43（5）：427-433．DOI：10.5543/tkda.2015.89439.
［25］PI?A I L，LIN L，WEINFURT K P，et al．Hemoglobin，exercise training，and health status in patients with chronic heart failure（from the HF-ACTION randomized controlled trial）［J］．Am J Cardiol，2013，112（7）：971-976．DOI：10.1016/j.amjcard.2013.05.033.
［26］徐帅，王莉．外周血中性粒细胞/淋巴细胞比值与急性ST段抬高型心肌梗死患者急性肾损伤的关系研究［J］．实用心脑肺血管病杂志，2017，25（11）：26-29．DOI：10.3969/j.issn.1008-5971.2017.11.007.
XU S，WANG L．Relationship between neutrophilia/lymphocyte ratio and acute kidney injury in patients with acute ST segment elevation myocardial infarction［J］．Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease，2017，25（11）：26-29．DOI：10.3969/j.issn.1008-5971.2017.11.007.
［27］SMITH G L，RADFORD M J，RATHORE S S，et al．Elevated serum creatinine and increased mortality in women and elderly heart failure patients［J］．J Am Coll Cardiol，2002，39：441．DOI：10.1016/S0735-1097（02）81983-0.
［28］ALEHAGEN U，DAHLSTR?M U，LINDAHL T L.Cystatin C and NT-proBNP，a powerful combination of biomarkers for predicting cardiovascular mortality in elderly patients with heart failure：results from a 10-year study in primary care［J］．European Journal of Heart Failure，2014，11（4）：354-360．DOI.org/10.1093/eurjhf/hfp024.

[1]	YANG Ling, DU Xueping. Application of Murtagh Safe Diagnostic Strategy Combined with Mind Mapping for Establishing Clinical Thinking in General Practice Teaching Clinic [J]. Chinese General Practice, 2025, 28(06): 673-680.
[2]	BAI Lu, ZHANG Qiang, LIU Fangfang, SUN Caihong, FEI Sijie, XIN Caifeng. Correlation between Triglyceride Glucose Index and Atrial Fibrillation in Patients with Chronic Heart Failure [J]. Chinese General Practice, 2025, 28(06): 720-728.
[3]	ZHU Lu, AI Jun, LIAO Shengwu, HUANG Shuting, GONG Nirong, KONG Yaozhong, LIU Dehui, DOU Xianrui, ZHANG Guangqing. Association of Prognostic Nutritional Index with Cardiovascular Mortality in Patients with Peritoneal Dialysis: a Multicenter Retrospective Cohort Study [J]. Chinese General Practice, 2025, 28(05): 568-574.
[4]	LAI Fengxia, WANG Shihong, ZHAO Le, HUANG Ruixian, YANG Zihua, ZHANG Zhiyi, KONG Danli, DING Yuanlin. Analysis and Prediction of Incidence and Mortality Trends of Three Enteric Infectious Diseases in China from 1990 to 2019 [J]. Chinese General Practice, 2025, 28(03): 313-319.
[5]	LU Jing, SUN Guozhen, WANG Jie, GAO Min, YU Tianxi, SUN Shuyi, WANG Qin, WEN Gaoqin. Interpretable Analysis of Influencing Factors and the Current State of Social Frailty in Patients with Chronic Heart Failure [J]. Chinese General Practice, 2025, 28(02): 220-227.
[6]	LIU Mingbo, HE Xinye, YANG Xiaohong, WANG Zengwu. Interpretation of Report on Cardiovascular Health and Diseases in China 2023 [J]. Chinese General Practice, 2025, 28(01): 20-38.
[7]	ZHANG Jin, SUN Di, WANG Hao, SHI Cong, ZHAO Yihan, PAN Yijin, MU Zhuanzhuan, DING Zhiguo, LIN Yansong. Factors Influencing Biochemical Progression in Distant Metastatic Papillary Thyroid Carcinoma [J]. Chinese General Practice, 2024, 27(36): 4546-4553.
[8]	HUANG Kai, ZHANG Yi, YANG Chun, YANG Ling. Advances in Gut Microbiota in Heart Failure Combined with Depression [J]. Chinese General Practice, 2024, 27(35): 4455-4461.
[9]	CHEN Ruman, BAI Yafei, WANG Chunli, AN Na, XU Mingzhi, HE Jiqing, QI Yonghui, WANG Liheng, LI Hong. Combined Predictive Value of Neutrophil-to-lymphocyte Ratio and C-reactive Protein-to-albumin Ratio for All-cause Mortality Risk in Patients with Maintenance Hemodialysis: Cohort Study Followed for 5 Years [J]. Chinese General Practice, 2024, 27(35): 4397-4402.
[10]	LIU Shenxinyu, GAO Min, WANG Jie, BAO Zhipeng, YU Tianxi, TANG Zhijie, SUN Shuyi, SUN Guozhen. Construction of a Service Quality Assessment Indicator System for Home-based Rehabilitation APP for Heart Failure Patients [J]. Chinese General Practice, 2024, 27(30): 3758-3762.
[11]	CHEN Kejun, YANG Yifei, GONG Jing, YANG Binxu, ZHOU Jing. Application Progress of Electronic Health Technology in Home Management of Patients with Heart Failure [J]. Chinese General Practice, 2024, 27(26): 3212-3217.
[12]	GAO Min, SUN Guozhen, WANG Qianyi, WANG Jie, HUANG Yangxi, YU Tianxi, LIU Shenxinyu, WEN Gaoqin. Development of Exercise Rehabilitation Adherence Scale for Patients with Chronic Heart Failure and Test on Its Reliability and Validity [J]. Chinese General Practice, 2024, 27(25): 3150-3158.
[13]	HU Yuchi, DAI Songyuan, ZHAO Ling, ZHAO Lulu. Advances in the Application of Vagus Nerve Stimulation in Inflammation and Apoptosis Mechanism of Chronic Heart Failure [J]. Chinese General Practice, 2024, 27(24): 3044-3050.
[14]	YI Shengguo, CAO Yedi, ZHAO Xue, LU Guizhi, ZHANG Yang, CONG Tiechuan, ZHANG Lanbo, ZHANG Jixin, LIANG Zhenwei, QU Chenxue, ZHANG Junqing, GAO Ying. EZH2 Expression in B Cell Lymphocyte Subsets of Hashimoto's Thyroiditis and the Therapeutic Mechanism and Effect of Its Inhibitors [J]. Chinese General Practice, 2024, 27(21): 2639-2645.
[15]	FENG Chao, JIANG Hantao, FAN Guanwei, LI Lan, FENG Jinping. Retrospective Study on the Efficacy of Qi Li Qiang Xin Jiao Nang in Reducing the Risk of Diuretic Resistance in Patients with Acute Decompensated Chronic Heart Failure [J]. Chinese General Practice, 2024, 27(21): 2578-2585.